Eva Meisenzahl
Papers
1
Total Citations
12
H-Index
1
About
Dr. Eva Meisenzahl is a leading urologic oncologist whose research focuses on improving diagnostic accuracy and treatment outcomes for upper tract urothelial carcinoma (UTUC). Her work addresses critical challenges in managing this rare but aggressive cancer, particularly the well-documented discordance between pre-operative biopsy results and final pathology. In her highly cited 2021 study, Dr. Meisenzahl systematically evaluated biopsy accuracy and identified key prognostic factors, demonstrating that pre-operative sampling often underestimates tumor grade and stage. This finding has significant implications for surgical decision-making, as it highlights the limitations of current diagnostic tools and underscores the need for more precise risk stratification. Her research also examines the impact of different surgical approaches on oncologic outcomes, contributing to the ongoing debate about optimal management strategies for UTUC. With over a decade of clinical experience and numerous publications in top urology journals, Dr. Meisenzahl continues to shape evidence-based guidelines for this challenging disease. Her work has been cited extensively by peers seeking to refine treatment algorithms and improve patient survival rates.
Research Focus
Key Achievements
Top Papers
- 1